Independent Medical Education
Dermatology: Atopic Dermatitis
Lilly is committed to supporting high-quality education and QI initiatives that provide healthcare professionals (HCPs) with evidence-based, clinically relevant content that advances learners’ knowledge, competence, and performance in order to ultimately impact patient care. We believe quality education is an excellent source to accelerate evidence into practice for the best interest of HCPs and patients. This site shows independent accredited educational activities supported by Lilly via educational grants and targeted for HCPs. All accredited programs must follow the standards set forth in the ACCME Standards for Integrity and Independence in Accredited Continuing Education. All decisions related to the planning, faculty selection, content creation and delivery of accredited education are the sole responsibility of the providers and/or accreditors. Lilly does not support independent education, or any medical activities, for the purpose of encouraging off-label use of our products.
Because the ACCME Standards prohibit us from providing a direct link to the educational activity, you may have to search within the link using the title of the program.
Clinical Perspective on the Latest Data for Emerging Therapies Targeting IL-13 in Moderate-to-Severe Atopic Dermatitis
News style video sessions
Provider: Answers in CME Inc.
29-AUG-2022 to 28-AUG-2023
the symposium proceedings captured as an on-demand enduring activity
Provider: Board of Regents - Nevada System of Higher Education - Board of Regents - University of Nevada, Reno School of Medicine
15-NOV-2022 to 15-NOV-2023
Live Symposia at AAD
Provider: WebMD Health Corp. - Medscape LLC
In-Person: Satellite Symposium